🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA · Read original ↗
There is a small increase in the risk of Guillain-Barré syndrome following vaccination with Abrysvo (Pfizer respiratory syncytial virus (RSV) vaccine) and Arexvy (GSK RSV vaccine) in adults aged 60 years and older. Healthca…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.
More in Respiratory / COPD / Asthma
NICE
Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management (NICE NG115)
25 Mar 2026
NICE
Asthma: Diagnosis, Monitoring and Chronic Asthma Management (NICE NG80/BTS)
25 Mar 2026
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III…
25 Mar 2026